Mechanical ventilation in Duchenne patients with chronic respiratory insufficiency: Clinical implications of 20 years published experience

Chronic Respiratory Disease

Volumn 4, Issue 3, 2007, Pages 167-177

  Toussaint, M ^a,c   Chatwin, M ^b   Soudon, P ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c ZH Inkendaal ^*  (Belgium)

Author keywords

Duchenne; Hypercapnia; Neuromuscular diseases; Noninvasive ventilation; Respiratory failure

Indexed keywords

ARTIFICIAL VENTILATION; BLOOD GAS ANALYSIS; CARBON DIOXIDE TENSION; CHRONIC RESPIRATORY FAILURE; CLINICAL FEATURE; DISEASE COURSE; DUCHENNE MUSCULAR DYSTROPHY; FORCED EXPIRATORY VOLUME; HUMAN; INTERMITTENT POSITIVE PRESSURE VENTILATION; LUNG ALVEOLUS HYPOVENTILATION; LUNG GAS EXCHANGE; MEDICAL ETHICS; OXYGEN SATURATION; PATIENT COMPLIANCE; PEAK EXPIRATORY FLOW; POLYSOMNOGRAPHY; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SUPINE POSITION; SURVIVAL RATE; SURVIVAL TIME; SYMPTOM; VENTILATOR;

CLINICAL TRIALS AS TOPIC; HUMANS; MUSCULAR DYSTROPHY, DUCHENNE; PERIODICALS AS TOPIC; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; TREATMENT OUTCOME;

EID: 35348967896     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972307080697     Document Type: Review

References (133)

1. Rideau Y, Gatin G, Bach J et al. Prolongation of life in Duchenne's muscular dystrophy. Acta Neurol 1983; 5: 118-124.
2. Phillips MF, Quinlivan RC, Edwards RH et al. Changes in spirometry over time as a prognostic marker in patients with Duchenne muscular dystrophy. Am J Respir Crit Care Med 2001; 164: 2191-4.
3. Rideau Y, Jankowski LW, Grellet J. Respiratory function in the muscular dystrophies. Muscle Nerve 1981; 4: 155-164.
4. Baydur A, Gilgoff I, Prentice W et al. Decline in respiratory function and experience with long-term assisted ventilation in advanced Duchenne's muscular dystrophy. Chest 1990; 97: 884-9.
5. Inkley SR, Oldenburg FC, Vignos PJ Jr. Pulmonary function in Duchenne muscular dystrophy related to stage of disease. Am J Med 1974; 56: 297-306.
6. Phillips MF, Smith PE, Carroll N et al. Nocturnal oxygenation and prognosis in Duchenne muscular dystrophy. Am J Respir Crit Care Med 1999; 160: 198-202.
7. Ragette R, Mellies U, Schwake C et al. Patterns and predictors of sleep disordered breathing in primary myopathies. Thorax 2002; 57: 724-28.
8. Hukins CA, Hillman DR. Daytime predictors of sleep hypoventilation in Duchenne muscular dystrophy. Am J Respir Crit Care Med 2000; 161: 166-170.
9. Simonds AK, Muntoni F, Heather S et al. Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy. Thorax 1998; 53: 949-52.
10. Soudon P, Wouters A, Kulakowski S. pO2-pCO2. Transcutaneous monitoring during sleep and ventilatory function in X-linked progressive muscular dystrophies. Cardiomyology 1984; 3: 21-38.
11. Suresh S, Wales P, Dakin C et al. Sleep-related breathing disorder in Duchenne muscular dystrophy: disease spectrum in the paediatric population. J Paediatr Child Health 2005; 41: 500-3.
12. Vianello A, Bevilacqua M, Salvador V et al. Long-term nasal intermittent positive pressure ventilation in advanced Duchenne's muscular dystrophy. Chest 1994; 105: 445-48.
13. Curran FJ. Night ventilation by body respirators for patients in chronic respiratory failure due to late stage Duchenne muscular dystrophy. Arch Phys Med Rehabil 1981; 62: 270-74.
14. Mohr CH, Hill NS. Long-term follow-up of nocturnal ventilatory assistance in patients with respiratory failure due to Duchenne-type muscular dystrophy. Chest 1990; 97: 91-96.
15. Soudon P, Steens M, Toussaint M et al. Ventilation assistée au long cours dans les maladies neuro-musculaires. Louvain Med 1991; 110: 235-53.
16. Bach JR, O'Brien J, Krotenberg R, Alba AS. Management of end stage respiratory failure in Duchenne muscular dystrophy. Muscle Nerve 1987; 10: 177-182.
17. Leger P, Bedicam JM, Cornette A et al. Nasal intermittent positive pressure ventilation. Long-term follow-up in patients with severe chronic respiratory insufficiency. Chest 1994; 105: 100-5.
18. Rideau Y, Delaubier A, Guillou C et al. Treatment of respiratory insufficiency in Duchenne's muscular dystrophy: nasal ventilation in the initial stages. Monaldi Arch Chest Dis 1995; 50: 235-38.
19. Fanfulla F, Berardinelli A, Gualtieri G et al. The efficacy of noninvasive mechanical ventilation on nocturnal hypoxaemia in Duchenne's muscular dystrophy. Monaldi Arch Chest Dis 1998; 53: 9-13.
20. Baydur A, Layne E, Aral H et al. Long term non-invasive ventilation in the community for patients with musculoskeletal disorders: 46 year experience and review. Thorax 2000; 55: 4-11.
21. Mellies U, Ragette R, Dohna Schwake C et al. Long-term noninvasive ventilation in children and adolescents with neuromuscular disorders. Eur Respir J 2003; 22: 631-36.
22. Ward S, Chatwin M, Heather S et al. Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax 2005; 60: 1019-24.
23. Anonymous. Consensus conference. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation: a consensus conference report. Chest 1999; 116: 521-34.
24. Coccagna G, Mantovani M, Parchi C et al. Alveolar hypoventilation and hypersomnia in myotonic dystrophy. J Neurol Neurosurg Psychiatry 1975; 38: 977-84.
25. Ellis ER, Bye PT, Bruderer JW et al. Treatment of respiratory failure during sleep in patients with neuromuscular disease. Positive-pressure ventilation through a nose mask. Am Rev Respir Dis 1987; 135: 148-52.
26. Smith PE, Calverley PM, Edwards RH. Hypoxemia during sleep in Duchenne muscular dystrophy. Am Rev Respir Dis 1988; 137: 884-88.
27. Schonhofer B, Geibel M, Sonneborn M et al. Daytime mechanical ventilation in chronic respiratory insufficiency. Eur Respir J 1997; 10: 2840-46.
28. Carroll N, Bain RJ, Smith PE et al. Domiciliary investigation of sleep-related hypoxaemia in Duchenne muscular dystrophy. Eur Respir J 1991; 4: 434-40.
29. Barbe F, Quera-Salva MA, McCann C et al. Sleep-related respiratory disturbances in patients with Duchenne muscular dystrophy. Eur Respir J 1994; 7: 1403-8.
30. Hess DR. Noninvasive ventilation in neuromuscular disease: equipment and application. Respir Care 2006; 51: 896-911.
31. Ragette R, Mellies U, Schwake C et al. Sleep-disordered breathing in neuromuscular diseases. Pneumologie 2003; 57: 729-33.
32. Khan Y, Heckmatt JZ. Obstructive apnoeas in Duchenne muscular dystrophy. Thorax 1994; 49: 157-61.
33. Bourke SC, Gibson GJ. Sleep and breathing in neuromuscular disease. Eur Respir J 2002; 19: 1194-1201.
34. Lofaso F, Quera-Salva MA. Polysomnography for the management of progressive neuromuscular disorders. Eur Respi J 2002; 19: 989-90.
35. Ramelli GP, Hammer J. Swiss physicians' practices of long-term mechanical ventilatory support of patients with Duchenne Muscular Dystrophy. Swiss Med Wkly 2005; 135: 599-604.
36. Fauroux B, Lofaso F. Non-invasive mechanical ventilation: when to start for what benefit? Thorax 2005; 60: 979-80.
37. Janssens JP, Howarth-Frey C, Chevrolet JC et al. Transcutaneous PCO2 to monitor noninvasive mechanical ventilation in adults: assessment of a new transcutaneous PCO2 device. Chest 1998; 133: 768-73.
38. Senn O, Clarenbach CF, Kaplan V et al. Monitoring carbon dioxide tension and arterial oxygen saturation by a single earlobe sensor in patients with critical illness or sleep apnea. Chest 2005; 128: 1291-96.
39. Herrejon A, Inchaurraga I, Palop J et al. Usefulness of transcutaneous carbon dioxide pressure monitoring to measure blood gases in adults hospitalized for respiratory disease. Arch Bronconeumol 2006; 42: 225-29.
40. Cox M, Kemp R, Anwar S et al. Non-invasive monitoring of CO2 levels in patients using NIV for AECOPD. Thorax 2006; 61: 363-64.
41. Laub M, Berg S, Midgren B. Symptoms, clinical and physiological findings motivating home mechanical ventilation in patients with neuromuscular diseases. J Rehabil Med 2006; 38: 250-54.
42. Manni R, Zucca C, Galimberti CA et al. Nocturnal sleep and oxygen balance in Duchenne muscular dystrophy. A clinical and polygraphic 2-year follow-up study. Eur Arch Psychiatry Clin Neurosci 1991; 240: 255-57.
43. Lanini B, Misuri G, Gigliotti F et al. Perception of dyspnea in patients with neuromuscular disease. Chest 2001; 120: 402-8.
44. Hours S, Lejaille M, Pozzi D et al. Perceived inspiratory difficulty in neuromuscular patients with primary muscle disorders. Neuromuscul Disord 2004; 14: 289-96.
45. Lyager S, Steffensen B, Juhl B. Indicators of need for mechanical ventilation in Duchenne muscular dystrophy and spinal muscular atrophy. Chest 1995; 108: 779-85.
46. Mellies U, Ragette R, Schwake C et al. Daytime predictors of sleep disordered breathing in children and adolescents with neuromuscular disorders. Neuromuscul Disord 2003; 13: 123-8.
47. Mellies U, Dohna-Schwake C, Ragette R et al. Nocturnal noninvasive ventilation of children and adolescents with neuromuscular diseases: effects on sleep and symptoms. Wien Klin Wochenschr 2003; 115: 855-59.
48. Toussaint M, Steens M, Wasteels G et al. Diurnal ventilation via mouthpiece: survival in end-stage Duchenne patients. Eur Respir J 2006; 28: 549-55.
49. Yasuma F, Kato T, Matsuoka Y et al. Row-a-boat phenomenon: respiratory compensation in advanced Duchenne muscular dystrophy. Chest 2001; 119: 1836-39.
50. Nicot F, Hart N, Forin V et al. Respiratory muscle testing: a valuable tool for children with neuromuscular disorders. Am J Respir Crit Care Med 2006; 174: 67-74.
51. Kang SW, Kang YS, Sohn HS et al. Respiratory muscle strength and cough capacity in patients with Duchenne muscular dystrophy. Yonsei Med J 2006; 47: 184-190.
52. Chaudri MB, Liu C, Hubbard R et al. Relationship between supramaximal flow during cough and mortality in motor neurone disease. Eur Respir J 2002; 19: 434-38.
53. Gauld LM, Boynton A. Relationship between peak cough flow and spirometry in Duchenne muscular dystrophy. Pediatr Pulmonol 2005; 39: 457-60.
54. Iandelli I, Gorini M, Misuri G, Gigliotti F, Rosi E, Duranti R, Scano G. Assessing inspiratory muscle strength in patients with neurologic and neuromuscular disease. Chest 2001; 119: 1108-13.
55. Eagle M, Baudouin SV, Chandler C et al. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 2002; 12: 926-29.
56. Canny GJ, Szeinberg A, Koreska J et al. Hypercapnia in relation to pulmonary function in Duchenne muscular dystrophy. Pediatr Pulmonol 1989; 6: 169-171.
57. Braun NM, Arora NS, Rochester DF. Respiratory muscle and pulmonary function in polymyositis and other proximal myopathies. Thorax 1983; 38: 616-23.
58. Yang KL. Inspiratory pressure/maximal inspiratory pressure ratio: a predictive index of weaning outcome. Intensive Care Med 1993; 19: 204-8.
59. Vassilakopoulos T, Zakynthinos S, Roussos C. The tension-time index and the frequency/tidal volume ratio are the major pathophysiologic determinants of weaning failure and success. Am J Respir Crit Care Med 1998; 158: 378-85.
60. Koga T, Watanabe K, Sano M et al. Breathing intolerance index: a new indicator for ventilator use. Am J Phys Med Rehabil 2006; 85: 24-30.
61. Misuri G, Lanini B, Gigliotti F et al. Mechanism of CO(2) retention in patients with neuromuscular disease. Chest 2000; 117: 447-53.
62. Fanfulla F, Delmastro M, Berardinelli A et al. Effects of different ventilator settings on sleep and inspiratory effort in patients with neuromuscular disease. Am J Respir Crit Care Med 2005; 172: 619-24.
63. Matecki S, Topin N, Hayot M et al. A standardized method for the evaluation of respiratory muscle endurance in patients with Duchenne muscular dystrophy. Neuromuscul Disord 2001; 11: 171-77.
64. Panitch HB. Respiratory issues in the management of children with neuromuscular disease. Respir Care 2006; 51: 885-93.
65. Raphael JC, Chevret S, Chastang C et al. Randomised trial of preventive nasal ventilation in Duchenne muscular dystrophy. French Multicentre Cooperative Group on Home Mechanical Ventilation Assistance in Duchenne de Boulogne Muscular Dystrophy. Lancet 1994; 343: 1600-4.
66. Howard RS, Davidson C. Long term ventilation in neurogenic respiratory failure. J Neurol Neurosurg Psychiatry 2003; 74: 24-30.
67. Simonds AK. Home ventilation. Eur Respir J Suppl 2003; 47: S38-46.
68. Kohler M, Clarenbach CM, Boni L et al. Quality of life, physical disability, and respiratory impairment in Duchenne muscular dystrophy. Am J Respir Crit Care Med 2005; 172: 1032-36.
69. Ogata K, Kohno S, Komiya T et al. Different mechanism may underlie respiratory failure of myotonic and Duchenne muscular dystrophies: a pulseoxymetric and spirometric study. Rinsho Shinkeigaku 1996; 36: 850-53.
70. Robert D, Willig TN, Leger P et al. Long-term nasal ventilation in neuromuscular disorders: report of a consensus conference. Eur Respir J 1993; 6: 599-606.
71. Hahn A, Bach JR, Delaubier A et al. Clinical implications of maximal respiratory pressure determinations for individuals with Duchenne muscular dystrophy. Arch Phys Med Rehabil 1997; 78: 1-6.
72. Servera E, Sancho J, Zafra MJ et al. Alternatives to endotracheal intubation for patients with neuromuscular diseases. Am J Phys Med Rehabil 2005; 84: 851-57.
73. Tzeng AC, Bach JR. Prevention of pulmonary morbidity for patients with neuromuscular disease. Chest 2000; 118: 1390-96.
74. Gomez-Merino E, Bach JR. Duchenne muscular dystrophy: prolongation of life by noninvasive ventilation and mechanically assisted coughing. Am J Phys Med Rehabil 2002; 81: 411-15.
75. Benditt JO. Full-time noninvasive ventilation: possible and desirable. Respir Care 2006; 51: 1005-12.
76. Hill NS. Neuromuscular disease in respiratory and critical care medicine. Respir Care 2006; 51: 1065-71.
77. Leger P, Paulus J. Summary: Recommendations of HAS: Practical issues in home non-invasive ventilation in patients with neuromuscular disease. Rev Mal Respir Suppl 2006; 23: S141-43.
78. Parker AE, Robb SA, Chambers J et al. Analysis of an adult Duchenne muscular dystrophy population. QJM 2005; 98: 729-36.
79. Schonhofer B, Sonneborn M, Haidl P et al. Comparison of two different modes for noninvasive mechanical ventilation in chronic respiratory failure: volume versus pressure controlled device. Eur Respir J 1997; 10: 184-191.
80. Chadda K, Clair B, Orlikowski D et al. Pressure support versus assisted controlled noninvasive ventilation in neuromuscular disease. Neurocrit Care 2004; 1: 429-34.
81. Kreit JW, Capper MW, Eschenbacher WL. Patient work of breathing during pressure support and volume-cycled mechanical ventilation. Am J Respir Crit Care Med 1994; 149: 1085-91.
82. Girault C, Richard JC, Chevron V et al. Comparative physiologic effects of noninvasive assist-control and pressure support ventilation in acute hypercapnic respiratory failure. Chest 1997; 111: 1639-48.
83. Branson RD, Davis K Jr. Dual control modes: combining volume and pressure breaths. Respir Care Clin N Am 2001; 7: 397-408.
84. Keszler M. Volume-targeted ventilation. Early Hum Dev 2006; 82: 811-18.
85. Storre JH, Seuthe B, Fiechter R et al. Average volume-assured pressure support in obesity hypoventilation: A randomized crossover trial. Chest 2006; 130: 815-21.
86. Nava S, Ceriana P. Patient-ventilator interaction during noninvasive positive pressure ventilation. Respir Care Clin N Am 2005; 11: 281-93.
87. Sassoon CS, Foster GT. Patient-ventilator asynchrony. Curr Opin Crit Care 2001; 7: 28-33.
88. Meyer TJ, Pressman MR, Benditt J et al. Air leaking through the mouth during nocturnal nasal ventilation: effects on sleep quality. Sleep 1997; 20: 561-69.
89. Guilleminault C, Philip P, Robinson A. Sleep and neuromuscular disease: bilevel positive airway pressure by nasal mask as a treatment for sleep disordered breathing in patients with neuromuscular disease. J Neurol Neurosurg Psychiatry 1998; 65: 225-32.
90. Boitano LJ, Benditt JO. An evaluation of home volume ventilators that support open-circuit mouthpiece ventilation. Respir Care 2005; 50: 1457-61.
91. Bach JR, Alba AS, Saporito LR. Intermittent positive pressure ventilation via de mouth as an alternative to tracheostomy for 257 ventilator users. Chest 1993; 103: 174-182.
92. Parreira VF, Jounieaux V, Aubert G et al. Nasal two-level positive-pressure ventilation in normal subjects. Effects of the glottis and ventilation. Am J Respir Crit Care Med 1996; 153: 1616-23.
93. Baydur A, Kanel G. Tracheobronchomalacia and tracheal hemorrhage in patients with Duchenne muscular dystrophy receiving long-term ventilation with uncuffed tracheostomies. Chest 2003; 123: 1307-11.
94. Parreira VF, Jounieaux V, Delguste P et al. Determinants of effective ventilation during nasal intermittent positive pressure ventilation. Eur Respir J 1997; 10: 1975-82.
95. Leger P, Jennequin J, Gerard M et al. Home positive pressure ventilation via nasal mask for patients with neuromuscular weakness or restrictive lung or chest-wall disease. Respir Care 1989; 34: 73-77.
96. Piper AJ, Sullivan CE. Effects of long-term nocturnal nasal ventilation on spontaneous breathing during sleep in neuromuscular and chest wall disorders. Eur Respir J 1996; 9: 1515-22.
97. Barbe F, Quera-Salva MA, de Lattre J et al. Long-term effects of nasal intermittent positive-pressure ventilation on pulmonary function and sleep architecture in patients with neuromuscular diseases. Chest 1996; 110: 1179-83.
98. Janssens JP, Derivaz S, Breitenstein E et al. Changing patterns in long-term noninvasive ventilation: a 7-year prospective study in the Geneva Lake area. Chest 2003; 123: 67-79.
99. Chailleux E, Fauroux B, Binet F et al. Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. A 10-year analysis of ANTADIR Observatory. Chest 1996; 109: 741-19.
100. Lofaso F, Orlikowski D, Raphael J-C. Ventilatory assistance in patients with Duchenne muscular dystrophy. Eur Respir J 2006; 28: 468-69.
101. Soudon P. Mechanical ventilation by tracheostomy in neuromuscular diseases: experience and evaluation. Eur Respir Rev 1993; 3: 300-4.
102. Gatin G. The value of assisted ventilation in muscular dystrophies. Ann Med Phys 1983; 26: 111-28.
103. Shneerson JM, Simonds AK. Noninvasive ventilation for chest wall and neuromuscular disorders. Eur Respir J 2002; 20: 480-87.
104. Brooks D, King A, Tonack M et al. User perspectives on issues that influence the quality of daily life of ventilator-assisted individuals with neuromuscular disorders. Can Respir J 2004; 11: 547-54.
105. Dellborg C, Olofson J, Midgren B et al. Quality of life in patients with chronic alveolar hypoventilation. Eur Respir J 2002; 19: 113-20.
106. Goldstein RS, Psek JA, Gort EH. Home mechanical ventilation. Demographics and user perspectives. Chest 1995; 108: 1581-16.
107. Annane D, Chevrolet JC, Chevret S et al. Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders. Cochrane Database Syst Rev 2000; CD001941.
108. Konagaya M, Sakai M, Wakayama T et al. Effect of intermittent positive pressure ventilation on life-span and causes of death in Duchenne muscular dystrophy. Rinsho Shinkeigaku 2005; 45: 643-46.
109. Yasuma F, Sakai M, Matsuoka Y. Effects of noninvasive ventilation on survival in patients with Duchenne's muscular dystrophy. Chest 1996; 109: 590.
110. Jeppesen J, Green A, Steffensen BF et al. The Duchenne muscular dystrophy population in Denmark, 1977-2001: prevalence, incidence and survival in relation to the introduction of ventilator use. Neuromuscul Disord 2003; 13: 804-12.
111. Gibson B. Long-term ventilation for patients with Duchenne muscular dystrophy: physician's beliefs and practices. Chest 2001; 119: 940-46.
112. Simonds AK. Living ad dying with respiratory failure: facilitating decision making. Chron Respir Dis 2004; 1: 56-59.
113. Hill NS. Noninvasive ventilation. Does it work, for whom, and how? Am Rev Respir Dis 1993; 147: 1050-5.
114. Carrey Z, Gottfried SB, Levy RD. Ventilatory muscle support in respiratory failure with nasal positive pressure ventilation. Chest 1990; 97: 150-58.
115. Vassilakopoulos T, Zakynthinos S, Roussos C. Bench-to-bedside review: Weaning failure: should we rest the respiratory muscles with controlled mechanical ventilation? Crit Care 2006; 10: 204.
116. McCool FD, Mayewski RF, Shayne DS et al. Intermittent positive pressure breathing in patients with respiratory muscle weakness. Alterations in total respiratory system compliance. Chest 1986; 90: 546-52.
117. De Troyer A, Deisser P. The effects of intermittent positive pressure breathing on patients with respiratory muscle weakness. Am Rev Respir Dis 1981; 124: 132-27.
118. Turkington PM, Elliott MW. Rationale for the use of non-invasive ventilation in chronic ventilatory failure. Thorax 2000; 55: 417-23.
119. Meyer TJ, Hill NS. Noninvasive positive pressure ventilation to treat respiratory failure. Ann Intern Med 1994; 120: 760-70.
120. Goldstein RS, Molotiu N, Skrastins R et al. Reversal of sleep-induced hypoventilation and chronic respiratory failure by nocturnal negative pressure ventilation in patients with restrictive ventilatory impairment. Am Rev Respir Dis 1987; 135: 1049-55.
121. Annane D, Quera-salva MA, Lofaso F et al. Mechanisms underlying effects of nocturnal ventilation on daytime blood gases in neuromuscular diseases. Eur Respir J 1999; 13: 157-62.
122. Dellborg C, Olofson J, Hamnegard CH et al. Ventilatory response to CO2 re-breathing before and after nocturnal nasal intermittent positive pressure ventilation in patients with chronic alveolar hypoventilation. Respir Med 2000; 94: 1154-60.
123. Nickol AH, Hart N, Hopkinson NS et al. Mechanisms of improvement of respiratory failure in patients with restrictive thoracic disease treated with non-invasive ventilation. Thorax 2005; 60: 754-60.
124. Ergun P, Aydin G, Turay UY et al. Short-term effect of nasal intermittent positive-pressure ventilation in patients with restrictive thoracic disease. Respiration 2002; 69: 303-8.
125. Diaz O, Begin P, Andresen M et al. Physiological and clinical effects of diurnal noninvasive ventilation in hypercapnic COPD. Eur Respir J 2005; 26: 1016-23.
126. Leger P, Langevin B, Guez A et al. What to do when nasal ventilation fails for neuromuscular patients. Eur Respir Rev 1993; 3: 279-83.
127. Teschler H, Stampa J, Ragette R et al. Effects of mouth leak on effectiveness of nasal bilevel ventilatory assistance and sleep architecture. Eur Respir J 1999; 14: 1251-57.
128. Gonzales J, Sharshar T, Hart N et al. Air leaks during mechanical ventilation as a cause of persistent hypercapnia in neuromuscular disorders. Intensive Care Med 2003; 29: 596-602.
129. Parreira VF, Delguste P, Jounieaux V et al. Effectiveness of controlled and spontaneous modes in nasal two-level positive pressure ventilation in awake and asleep normal subjects. Chest 1997; 112: 1267-77.
130. Leger P. Long-term ventilation in restrictive ventilatory disorders. Respir Care Clin N Am 2002; 8: 507-32.
131. Windisch W, Dreher M, Storre JH et al. Nocturnal non-invasive positive pressure ventilation: physiological effects on spontaneous breathing. Respir Physiol Neurobiol 2006; 150: 251-60.
132. Katz S, Selvadurai H, Keilty K et al. Outcome of non-invasive positive pressure ventilation in paediatric neuromuscular disease. Arch Dis Child 2004; 89: 121-24.
133. Finder JD, Birnkrant D, Carl J et al. American Thoracic Society. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Care Med 2004; 170: 456-65.